Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Sundry Debtors

    Back to Balance Sheet
AUROBINDO PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Sundry Debtors History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Sundry Debtors ₹4,817 Cr₹4,466 Cr₹4,012 Cr₹3,503 Cr₹4,315 Cr

What is the latest Sundry Debtors ratio of AUROBINDO PHARMA ?

The latest Sundry Debtors ratio of AUROBINDO PHARMA is ₹4,817 Cr based on Mar2024 Consolidated results.
Year Sundry Debtors
Mar2024₹4,817 Cr
Mar2023₹4,466 Cr
Mar2022₹4,012 Cr
Mar2021₹3,503 Cr
Mar2020₹4,315 Cr

How is Sundry Debtors of AUROBINDO PHARMA Trending?

Years Sundry Debtors % Change
Mar2024 ₹4,817 Cr
7.84
Mar2023 ₹4,466 Cr
11.32
Mar2022 ₹4,012 Cr
14.53
Mar2021 ₹3,503 Cr
-18.81
Mar2020 ₹4,315 Cr -

Compare Sundry Debtors of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹64,297.5 Cr -4.2% -7.1% -11.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.3% -3.5% 9.2% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.8% 1.3% 42.3% Stock Analytics
CIPLA ₹121,023.0 Cr -0.3% 3% -2.6% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -3.7% 7.2% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,204.0 Cr -1% -0.5% 13.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-4.2%

-7.1%

-11.6%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses